Clinical Trial

Hepatic Lipid Metabolism-Alcohol Use Disorder

Name: Hepatic Lipid Metabolism-Alcohol Use Disorder — clinical trial record (NCT07191561)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. The first biopsy will occur in the first week of admission and the second in the fourth week when the steatosis has resolved. The hepatic transcriptome will be compared,

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-16

Trial Details

NCT Number	NCT07191561
Lead Sponsor	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions	Alcohol Use Disorder
Enrollment	25 participants
Start Date	2026-08-19
Primary Completion	2027-11-30 (estimated)
Study Completion	2029-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-14